✦ New CED Clinical Relevance #86High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient AccessRegulationState Programs Why This MattersGeorgia's evolving cannabis legislation directly impacts patient...
Cannabis Purity Concerns Grow As Consumers Shift From Alcohol – Forbes
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyContaminationQuality ControlAlcohol SubstitutionRegulatory Policy Why This MattersAs cannabis increasingly substitutes for alcohol in...
Texas smokable hemp ban reversed: How THC flower returned to Austin shelves
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic HempLegal AccessRegulatory PolicyPatient SafetyThc Why This MattersLegal access to smokable hemp products affects patient...
Medicinal Cannabis Export Licenses Take 6.4 Working Days In 2026 – Scoop
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic RegulationSupply ChainInternational PolicyProduct AccessQuality Control Why This MattersExport license processing times directly impact global...
HLB Life Science R&D leads Korea CBD drug ingredient push in national project
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdPharmaceutical DevelopmentRegulatory PolicyAsiaDrug Manufacturing Why This MattersKorea's formal entry into pharmaceutical-grade CBD development represents...
Ontario considering allowing legal cannabis stores to open earlier – CP24
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyAccessRegulationPatient CareDispensaries Why This MattersExtended retail hours may improve patient access to cannabis medicines,...
Maine debates the best method to test, track medical cannabis products
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Quality ControlPatient SafetyRegulatory PolicyLaboratory TestingMedical Cannabis Why This MattersLaboratory testing and tracking systems directly...
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PsilocybinMushroomsGoingMainstream Why This MattersThis item covers developments relevant to cannabis medicine and clinical...
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin
While smaller trials and systematic reviews indicate therapeutic potential, the quality of evidence is often low due to limited sample sizes, short study durations, and methodological inconsistencies. Large-scale, randomized controlled trials with long-term follow-up are urgently needed.
Cannabis bill increasing amount of weed users can buy in MA passes House – Worcester Telegram
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPatient AccessMassachusettsRegulationMedical Cannabis Why This MattersPurchase limit changes directly impact patient access to cannabis...